Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

03/08/2022 05:30

Aug 3 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.20               18.45            76.40    
                 (-1.4 pct)          (+2.1 pct)       (+0.5 pct)  
  Operating          4.06                4.42            15.00    
                 (-8.3 pct)          (-12.1 pct)      (-12.1 pct) 
  Recurring          4.33                4.66            15.50    
                 (-7.0 pct)          (-11.2 pct)      (-11.6 pct) 
  Net                2.91                3.36            12.00    
                 (-13.5 pct)         (-12.0 pct)      (+25.7 pct) 
  EPS             76.91 yen           87.78 yen       318.78 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div                             75.00 yen        75.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T